Screening for peripheral neuropathy and peripheral arterial disease in persons with diabetes mellitus in a Nigerian University Teaching Hospital

BMC Research Notes

Alfred Azenabor³  Babatunde Solagberu¹  Olufunmilayo Adeleye²  Anthonia O. Ogbera⁴ 

[1] Department of Surgery, Lagos State University College Of Medicine, Ikeja, Lagos, Nigeria;Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria;Department of Medical Laboratory Sciences, University of Lagos, Idi-araba, Lagos, Nigeria;Department of Medicine, Lagos State University College Of Medicine, Ikeja, Lagos, Nigeria

关键词: Peripheral arterial disease;    Neuropathy;    Diabetes mellitus;   

Others  :  1229863
DOI  :  10.1186/s13104-015-1423-2

 received in 2014-11-14, accepted in 2015-09-07,  发布年份 2015

【 摘 要 】

Background

Identifying the risk factors for diabetes mellitus related foot ulceration would save more limbs from amputation. This report focuses on the determining the burden of peripheral arterial disease and neuropathy in persons with diabetes mellitus (DM).

Methods

This is a descriptive study carried out in the Diabetic Clinic of the Lagos State University Teaching Hospital in patients with DM who had no past/present history of foot ulceration. Biothesiometry was employed and ankle brachial pressure indices were measured to evaluate for neuropathy and peripheral arterial disease (PAD) respectively.

Results

A total of 225 persons living with DM who met inclusion criteria were recruited consecutively over a 3 months period. Age range was 28–87 years with the mean [61.4 (10.8)] and median (63) years respectively. Patients symptomatic for neuropathy and PAD were 37 and 40 % respectively of the study population. An older age of >60 years and poor glycaemic control were potential predictors of neuropathy. Neuropathy and PAD occurred commonly in the seventh decade of life.

Conclusion

Given the fairly high proportions of neuropathy and PAD in our patients with DM, we recommend that they be routinely examined in persons with DM.

【 授权许可】

   
2015 Ogbera et al.

【 图 表 】

Fig.1.

Fig.2.

【 参考文献 】

• [1]Jayaprakash P, Bhansali A, Bhansali S, Dutta P, Anantharaman R, Shanmugasundar G, et al.: Validation of bedside methods in evaluation of diabetic peripheral neuropathy. Indian J Med Res 2011, 133(6):645-649.
• [2]Ogbera AO, Adedokun A, Fasanmade OA, Ohwovoriole AE, Ajani M: The foot at risk in Nigerians with diabetes mellitus: the Nigerian scenario. Int J Endocrinol Metabol 2005, 4:165-173.
• [3]Chinenye S, Uloko AE, Ogbera AO, Ofoegbu EN, Fasanmade OA, Fasanmade AA, Ogbu OO: Profile of Nigerians with diabetes mellitus—Diabcare Nigeria study group (2008): results of a multicenter study. Indian J Endocr Metab 2012, 16:558-564.
• [4]Kinnear TWG: The pattern of diabetes mellitus in a Nigerian teaching hospital. East Afr Med J 1963, 40:288-294.
• [5]Osuntokun BO, Akinkugbe FM, Francis TI, Reddy S, Taylor GOL: Diabetes mellitus in Nigerians: a study of 832 patients. West Afr Med J 1971, 20:295-312.
• [6]Oyelade BO, OlaOlorun AD, Odeigah LO, Amole IO, Adediran OS: The prevalence of peripheral arterial disease in diabetic subjects in southwest Nigeria. Afr J Prm Health Care Fam Med. 2012, 4(1):354-356.
• [7]Saha D, Saha K, Dasgupta PK: Vibration sense impairment in diabetes mellitus. Indian J Physiol Pharmacol 2011, 55:381-383.
• [8]American Diabetes Association: Peripheral arterial disease in people with diabetes Diabetes Care 2006, 26(12):3333-3341.
• [9]American Diabetes Association: Standards of medical care in diabetes-2015 Diabetes Care 2015, 38(1):S1-S94.
• [10]Ogbera AO, Fasanmade O, Chinenye S, et al.: Characterization of lipid parameters in diabetes mellitus—a Nigerian report. Int Archiv Med 2009, 2:19. BioMed Central Full Text
• [11]Tochman-Gawda A, Paprzycki P, Dziemidok P: A tuning fork or a biothesiometer: which one to choose in the outpatient diabetes care? Diabetologia Doświadczalna i Kliniczna 2007, 7:13-19.
• [12]Oguejiofor OC, Odenigbo CU, Oguejiofor CB: Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry. Niger J Clin Pract. 2010, 13(3):240-247.
• [13]Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD: Prevalence of diabetic peripheral neuropathy and its relation to glycemic control and potential risk factors. The Euro Diab IDDM complications study. Diabetologia 1996, 39(11):1377-1384.
• [14]Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J: Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol 2005, 5:24. BioMed Central Full Text
• [15]Ashok S, Ramu M, Deepa R, Mohan V: Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. J Assoc Physicians India 2002, 50:546-550.
• [16]American Diabetes Association: Implications of the United Kingdom prospective diabetes study Diabetes Care 2002, 25(1):s28-s32.
• [17]Bruce GS, Young K: Prevalence and risk factors for neuropathy in a Canadian first nation community. Diabetes Care 2008, 31:1837-1841.
• [18]Kelkar P: Diabetic neuropathy. Semin Neurol 2005, 25(2):168-173.
• [19]Ogbera O, Chinenye S, Onyekwere C, Fasanmade A: Prognostic indices of DM mortality. Ethn Dis 2007, 17(4):721-725.
• [20]Mwebaze RM, Kibirige D: Peripheral arterial disease among adult diabetic patients attending a large outpatient diabetic clinic at a National Referral Hospital in Uganda: a descriptive cross sectional study. PLoS One 2014, 9(8):e105211.
• [21]Kengne PA, Amoah AGB, Mbanya JC: Cardiovascular complications of diabetes mellitus in Sub-Saharan Africa. Circulation 2005, 112(23):3592-3601.
• [22]Al-Qaisi M, Nott DM, King DH, Kaddoura S: Ankle brachial pressure index (ABPI): an update for practitioners. Vasc Health Risk Manag 2009, 5:833-841.